Drug Research
Northwest Biotherapeutics Announces Commencement Of Cancer Vaccine Production At Its Sawston, UK Facility
Northwest Biotherapeutic, a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced commencement of production of its first dendritic cell cancer vaccine for a compassionate use patient at its recently licensed production facility in Sawston, UK.
This...
Drug Research
BioGenes, Alphalyse partner to optimize ELISA reagent characterization for biomanufacturing
BioGenes has partnered with Alphalyse, a specialist contract research organization. Recently, two companies that have been active in the field of Host Cell Protein (HCP) detection for many years have partnered up to offer their respective methods to biologics...
Drug Research
Berkshire Sterile to offer formulation, lyophilization, and method development services
Berkshire Sterile Manufacturing (BSM), a sterile filling contract manufacturer located in Lee, MA, has recently added formulation, lyophilization, and method development capabilities to complement their clients’ drug productions.
BSM will now offer first-in-human formulation development, supply material for preclinical studies,...
Drug Research
Seqirus Announces New Facility Supporting Research & Development of Leading-Edge Influenza Vaccine Technology
Seqirus, a global leader in influenza prevention and a business of CSL Limited announced an investment in a new Research and Development (R&D) facility located in Waltham, Mass. The new facility will support the company’s growing R&D portfolio, with...
Drug Research
Piramal Pharma Solutions Strengthens UK Presence with the Expansion and Upgrade of its Grangemouth and Morpeth Facilities
Piramal Pharma Limited’s Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), announced the expansion of its Antibody-Drug Conjugate (ADC) capabilities at the Grangemouth facility in Scotland and the investment in new Active Pharmaceutical Ingredient (API) infrastructure...
Drug Research
DuPont invests in bioprocessing supply chain to enhance purchasing of its products for drug development
DuPont has launched a new online sales portal tailored to the needs of bioprocessing industry purchasers. The portal handles online sales transactions, with target lead times of < 1 week.
DuPont’s bioprocessing solutions enable sophisticated purifications and separations for therapeutics...
Drug Research
Cytiva and NecstGen form strategic collaboration to accelerate development of cell and gene therapies
Cytiva, a global life sciences leader, and NecstGen, aim to accelerate the development of new cell and gene therapies globally via a strategic collaboration. Cytiva will provide its technologies, services, and solutions to NecstGen, and both organizations will share...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read